학술논문
Three-Year Safety, Tolerability, and Health-Related Quality of Life Outcomes of Adjuvant Osimertinib in Patients With Resected Stage IB to IIIA EGFR-Mutated NSCLC: Updated Analysis From the Phase 3 ADAURA Trial
Document Type
Article
Author
John, Thomas; Grohé, Christian; Goldman, Jonathan W.; Shepherd, Frances A.; de Marinis, Filippo; Kato, Terufumi; Wang, Qun; Su, Wu-Chou; Choi, Jin Hyuk; Sriuranpong, Virote; Melotti, Barbara; Fidler, Mary J.; Chen, Jun; Albayaty, Muna; Stachowiak, Marta; Taggart, Sarah; Wu, Yi-Long; Tsuboi, Masahiro; Herbst, Roy S.; Majem, Margarita
Source
In Journal of Thoracic Oncology September 2023 18(9):1209-1221
Subject
Language
ISSN
1556-0864